Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated Diarrhea
Dec. 15, 2011
Salix Pharmaceuticals announced that it has submitted to the FDA a new drug application for Crofelemer for the proposed treatment of HIV-associated diarrhea.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing